Prognostic usefulness of dyspnea versus fatigue as reason for exercise test termination in patients with heart failure

被引:19
作者
Chase, Paul [1 ]
Arena, Ross [2 ,3 ]
Myers, Jonathan [5 ]
Abella, Joshua [5 ]
Peberdy, Mary Ann [4 ]
Guazzi, Marco [6 ]
Kenjale, Aarti [1 ]
Bensimhon, Daniel [1 ]
机构
[1] LeBauer Cardiovasc Res Fdn, Greensboro, NC USA
[2] Virginia Commonwealth Univ, Dept Physiol, Richmond, VA USA
[3] Virginia Commonwealth Univ, Dept Phys Therapy, Richmond, VA USA
[4] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA
[5] Stanford Univ, Div Cardiol, VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA
[6] Univ Milan, Div Cardiol, Cardiopulm Lab, San Paolo Hosp, Milan, Italy
关键词
D O I
10.1016/j.amjcard.2008.05.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiopulmonary exercise testing (CPX) is an integral tool for assessing the clinical status and prognosis of patients with heart failure (HF). The present investigation examined differences in CPX variables and prognosis according to reason for test termination. One hundred eighty-three patients with HF (69% men, 31% women; mean age 53 +/- 13 years, left ventricular ejection fraction at rest 24.3 +/- 9.9%) underwent CPX in which the minute ventilation/carbon dioxide production slope, peak oxygen consumption, and peak respiratory exchange ratio were determined. Subjects were tracked for cardiac-related events for 2 years after CPX. Dyspnea and fatigue (general fatigue/leg fatigue) were the primary reasons for test termination in 79 and 104 patients, respectively. Peak oxygen consumption (15.4 +/- 5.7 vs 17.5 +/- 5.9 ml O-2 . kg(-1) . min(-1)) was significantly lower, whereas minute ventilation/carbon dioxide production slope (38.5 +/- 12.8 vs 33.9 +/- 9.8) was significantly higher in the dyspnea subgroup (p <0.05). There were 41 cardiac-related events during the 2-year tracking period. Patients with dyspnea were at significantly higher risk of adverse events (hazard ratio 2.1, 95% confidence interval 1.1 to 4.0, p = 0.02). In conclusion, these results indicate that patients with HF terminating an exercise test primarily because of dyspnea have an increased incidence of cardiac-related events and poorer CPX markers than those limited by fatigue. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:879 / 882
页数:4
相关论文
共 15 条
[1]   Prognostic significance of dyspnea in patients referred for cardiac stress testing [J].
Abidov, A ;
Rozanski, A ;
Hachamovitch, R ;
Hayes, SW ;
Aboul-Enein, F ;
Cohen, I ;
Friedman, JD ;
Germano, G ;
Berman, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (18) :1889-1898
[2]   Prognostic characteristics of cardiopulmonary exercise testing in heart failure: comparing American and European models [J].
Arena, R ;
Guazzi, M ;
Myers, J ;
Peberdy, MA .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2005, 12 (06) :562-567
[3]   Peak VO2 and VE/VCO2 slope in patients with heart failure:: A prognostic comparison [J].
Arena, R ;
Myers, J ;
Aslam, SS ;
Varughese, EB ;
Peberdy, MA .
AMERICAN HEART JOURNAL, 2004, 147 (02) :354-360
[4]   Development of a ventilatory classification system in patients with heart failure [J].
Arena, Ross ;
Myers, Jonathan ;
Abella, Joshua ;
Peberdy, Mary Ann ;
Bensimhon, Daniel ;
Chase, Paul ;
Guazzi, Marco .
CIRCULATION, 2007, 115 (18) :2410-2417
[5]   Reasons for terminating an exercise test provide independent prognostic information: 2014 apparently healthy men followed for 26 years [J].
Bodegard, J ;
Erikssen, G ;
Bjornholt, JV ;
Gjesdal, K ;
Liestol, K ;
Erikssen, J .
EUROPEAN HEART JOURNAL, 2005, 26 (14) :1394-1401
[6]   Inspiratory muscle load and capacity in chronic heart failure [J].
Hart, N ;
Kearney, MT ;
Pride, NB ;
Green, M ;
Lofaso, F ;
Shah, AM ;
Moxham, J ;
Polkey, MI .
THORAX, 2004, 59 (06) :477-482
[7]  
Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022
[8]   Impairment of ventilatory efficiency in heart failure - Prognostic impact [J].
Kleber, FX ;
Vietzke, G ;
Wernecke, KD ;
Bauer, U ;
Opitz, C ;
Wensel, R ;
Sperfeld, A ;
Gliser, S .
CIRCULATION, 2000, 101 (24) :2803-2809
[9]  
Meyer FJ, 2001, CIRCULATION, V103, P2153
[10]   Standardisation of spirometry [J].
Miller, MR ;
Hankinson, J ;
Brusasco, V ;
Burgos, F ;
Casaburi, R ;
Coates, A ;
Crapo, R ;
Enright, P ;
van der Grinten, CPM ;
Gustafsson, P ;
Jensen, R ;
Johnson, DC ;
MacIntyre, N ;
McKay, R ;
Navajas, D ;
Pedersen, OF ;
Pellegrino, R ;
Viegi, G ;
Wanger, J .
EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (02) :319-338